These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 32830433

  • 1. α-Mangostin-encapsulated PLGA nanoparticles inhibit colorectal cancer growth by inhibiting Notch pathway.
    Chandra Boinpelly V, Verma RK, Srivastav S, Srivastava RK, Shankar S.
    J Cell Mol Med; 2020 Oct; 24(19):11343-11354. PubMed ID: 32830433
    [Abstract] [Full Text] [Related]

  • 2. α-Mangostin-encapsulated PLGA nanoparticles inhibit pancreatic carcinogenesis by targeting cancer stem cells in human, and transgenic (Kras(G12D), and Kras(G12D)/tp53R270H) mice.
    Verma RK, Yu W, Shrivastava A, Shankar S, Srivastava RK.
    Sci Rep; 2016 Sep 14; 6():32743. PubMed ID: 27624879
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sanguinarine inhibits pancreatic cancer stem cell characteristics by inducing oxidative stress and suppressing sonic hedgehog-Gli-Nanog pathway.
    Ma Y, Yu W, Shrivastava A, Alemi F, Lankachandra K, Srivastava RK, Shankar S.
    Carcinogenesis; 2017 Oct 01; 38(10):1047-1056. PubMed ID: 28968696
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Zerumbone inhibits epithelial-mesenchymal transition and cancer stem cells properties by inhibiting the β-catenin pathway through miR-200c.
    Dermani FK, Amini R, Saidijam M, Pourjafar M, Saki S, Najafi R.
    J Cell Physiol; 2018 Dec 01; 233(12):9538-9547. PubMed ID: 29943808
    [Abstract] [Full Text] [Related]

  • 8. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells.
    Nalls D, Tang SN, Rodova M, Srivastava RK, Shankar S.
    PLoS One; 2011 Dec 01; 6(8):e24099. PubMed ID: 21909380
    [Abstract] [Full Text] [Related]

  • 9. ZnAs@SiO2 nanoparticles as a potential anti-tumor drug for targeting stemness and epithelial-mesenchymal transition in hepatocellular carcinoma via SHP-1/JAK2/STAT3 signaling.
    Huang Y, Zhou B, Luo H, Mao J, Huang Y, Zhang K, Mei C, Yan Y, Jin H, Gao J, Su Z, Pang P, Li D, Shan H.
    Theranostics; 2019 Dec 01; 9(15):4391-4408. PubMed ID: 31285768
    [Abstract] [Full Text] [Related]

  • 10. Iguratimod encapsulated PLGA-NPs improves therapeutic outcome in glioma, glioma stem-like cells and temozolomide resistant glioma cells.
    Younis M, Faming W, Hongyan Z, Mengmeng T, Hang S, Liudi Y.
    Nanomedicine; 2019 Nov 01; 22():102101. PubMed ID: 31654739
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of PER3 Inhibits Self-Renewal Capability and Chemoresistance of Colorectal Cancer Stem-Like Cells via Inhibition of Notch and β-Catenin Signaling.
    Zhang F, Sun H, Zhang S, Yang X, Zhang G, Su T.
    Oncol Res; 2017 May 24; 25(5):709-719. PubMed ID: 27983919
    [Abstract] [Full Text] [Related]

  • 12. NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200.
    Fu J, Rodova M, Nanta R, Meeker D, Van Veldhuizen PJ, Srivastava RK, Shankar S.
    Neuro Oncol; 2013 Jun 24; 15(6):691-706. PubMed ID: 23482671
    [Abstract] [Full Text] [Related]

  • 13. Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells.
    Buhrmann C, Yazdi M, Popper B, Shayan P, Goel A, Aggarwal BB, Shakibaei M.
    Nutrients; 2018 Jul 12; 10(7):. PubMed ID: 30002278
    [Abstract] [Full Text] [Related]

  • 14. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
    Leng Z, Xia Q, Chen J, Li Y, Xu J, Zhao E, Zheng H, Ai W, Dong J.
    Cell Physiol Biochem; 2018 Jul 12; 46(2):860-872. PubMed ID: 29627827
    [Abstract] [Full Text] [Related]

  • 15. Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition.
    Shankar S, Nall D, Tang SN, Meeker D, Passarini J, Sharma J, Srivastava RK.
    PLoS One; 2011 Jan 31; 6(1):e16530. PubMed ID: 21304978
    [Abstract] [Full Text] [Related]

  • 16. Modified Shenlingbaizhu Decoction represses the pluripotency of colorectal cancer stem cells by inhibiting TGF-β mediated EMT program.
    Dai Y, Wang H, Sun R, Diao J, Ma Y, Shao M, Xu Y, Zhang Q, Gao Z, Zeng Z, Zhang L, Sun X.
    Phytomedicine; 2022 Aug 31; 103():154234. PubMed ID: 35689903
    [Abstract] [Full Text] [Related]

  • 17. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
    Xiao W, Gao Z, Duan Y, Yuan W, Ke Y.
    J Exp Clin Cancer Res; 2017 Mar 09; 36(1):41. PubMed ID: 28279221
    [Abstract] [Full Text] [Related]

  • 18. Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer.
    Zhang L, Xu L, Zhang F, Vlashi E.
    Cell Cycle; 2017 Apr 18; 16(8):737-745. PubMed ID: 27753527
    [Abstract] [Full Text] [Related]

  • 19. Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway.
    Zang MD, Hu L, Fan ZY, Wang HX, Zhu ZL, Cao S, Wu XY, Li JF, Su LP, Li C, Zhu ZG, Yan M, Liu BY.
    J Transl Med; 2017 Feb 27; 15(1):52. PubMed ID: 28241766
    [Abstract] [Full Text] [Related]

  • 20. α-Mangostin suppresses the viability and epithelial-mesenchymal transition of pancreatic cancer cells by downregulating the PI3K/Akt pathway.
    Xu Q, Ma J, Lei J, Duan W, Sheng L, Chen X, Hu A, Wang Z, Wu Z, Wu E, Ma Q, Li X.
    Biomed Res Int; 2014 Feb 27; 2014():546353. PubMed ID: 24812621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.